EMERGING ISRAELI BIOPHARMA FLIES FLAG FOR EX-BMS CANCER THERAPY by Phil Taylor | Apr 10, 2018 9:57am | FierceBiotech Israeli biotech Ayala Pharmaceuticals, founded last year as a development vehicle for two of Bristol-Myers Squibb’s cancer candidates, has raised $17 million in a series A financing. The new company licensed rights to BMS’s gamma secretase inhibitor BMS-906024 in December, [...]
10 Apr 2018 | MEDTECH NEWS by Catherine Longworth Israel has set its sights on becoming a global leader in digital health, boosted by the government's new five-year plan to invest nearly $300m to drive innovation in this space. Israel is on a mission. The self-dubbed "Start-Up Nation" has proclaimed its ambition to become the world's [...]
Dr. Barak Azmon, an ophthalmologist and serial entrepreneur, is convinced Israel can become a 'meaningful player' in vision-related developments By SHOSHANNA SOLOMON| April 2018, 12:31 pm | Times of Israel Dr. Barak Azmon, an ophthalmologist and serial entrepreneur, is convinced Israel can become a “meaningful player” in technologies relating to eyesight. He and his partners [...]
MIXiii-Biomed 2018 – Registration and program online MIXiii-Biomed 2018 is fast approaching. This prestigious conference and exhibition is once again ready to launch start-ups into the international arena and to help thousands of delegates connect and establish strong networking possibilities. REGISTER NOW Use this opportunity to participate and become a key player in the [...]
Dr. Arie Belldegrun, formerly Kite Pharma’s CEO, and Executive Chairman of Allogene Therapeutics, will be delivering the opening plenary talk at MIXiii-BIOMED conference, May 15-17, Tel Aviv. by john carroll — on April 3, 2018 08:00 AM EDT You need a license to cut-and-paste this copyrighted news content. Use this link to purchase your paid subscription ($200/year for individuals and [...]
Israel's 17th national life science and technology week to be held on May 15-17, 2018 at the David InterContinental Hotel in Tel Aviv NEWS PROVIDED BY MIXiii-BIOMED 07:30 ET | TEL AVIV, Israel, April 3, 2018 /PRNewswire/ The 17th annual MIXiii-BIOMED 2018, the premier international life science conference in Israel, will take place between May 15-17, 2018, at the David InterContinental Hotel in Tel [...]
April 2, 2018 | GEN News Highlights AstraZeneca’s #MedImmune subsidiary has agreed to exclusively license and develop #bispecific and multispecific #immuno-oncology antibody products from Compugen’s pipeline, through a collaboration that #Compugen said today could generate for it up to $210 million-plus. Compugen said it will grant MedImmune an exclusive license to develop bispecific and multispecific antibody products [...]
As part of the deal, InSight commits to help develop CureTech’s lead product, which is currently in advanced #clinical trials Lilach Baumer17:4228.03.18 Pharmaceutical company InSight Biopharmaceuticals Ltd. has signed a deal to acquire cancer treatment company CureTech Ltd. The announcement was made Wednesday by Clal Biotechnology Industries, which holds 53% of CureTech’s shares. As [...]
MIXiii-#BIOMED 2018 #Conference chair Ruti Alon: The pendulum has to move back to medical devices, after a decade in which the sector was starved of financing. For almost a decade, companies in the medical devices sector have lacked financing. Is this era about to end? A report published this month by rating agency [...]
The ambitious plan is designed to make Israel a digital health power and improve the health of its residents, and of the entire world. Israel's cabinet today approved a NIS 922 million budget for a national digital health project. The plan includes a number of elements, the combination of which is designed to make [...]